Professor and Associate Director; Research, Dalhousie University

Ingrid Sketris is a Professor of Pharmacy at Dalhousie University. She was President of the Association of Faculties of Pharmacy of Canada and is a fellow of the Canadian Society of Hospital Pharmacists and the American College of Clinical Pharmacy. She is one of 12 chairs funded by CHSRF/CIHR as part of the Capacity for Applied Developmental Research and Evaluation in Health Services program. Her research involves examining approaches to increase the uptake of evidence-based drug therapies and the effectiveness of policy levers used by pharmacare programs to provide effective and affordable ...


Director of Research, Centre hospitalier de l'Université de Montréal (CHUM)

Since spring 2007, Dr. Jacques Turgeon has been appointed Director of Research at the Centre hospitalier de l’Université de Montréal. From 2005-2007 he was Vice-Rector — Research, Université de Montréal after having served as Dean of the Faculté de Pharmacie there. Dr. Turgeon’s research interests have always been directed towards the study of factors responsible for inter-subject variability in drug response and specifically in the role of pharmacogenetics in cardiovascular drug actions. Dr. Turgeon has integrated in vitro (patch-clamp technique, in vitro metabolism and molecular biology) ...


Dr. McMaster is the Scientific Director of the Canadian Institutes of Health Research (CIHR) Institute of Genetics and Professor of Pharmacology at Dalhousie University in Halifax, Canada, Previously, Dr. McMaster was the Carnegie and Rockefeller Professor and Head of the Department of Pharmacology, co-Director of the Cheminformatics Drug Discovery Lab, and Assistant Dean for Graduate and Post-doctoral Studies in the Faculty of Medicine at Dalhousie University. His research encompasses several genetic models ranging from yeast to zebrafish to mice with the aim of finding therapies for ...


Professor, McGill University

Szyf received his Ph. D from the Hebrew University and did his postdoctoral fellowship in Genetics at Harvard Medical School, joined the department in 1989 and currently holds a James McGill Professorship and GlaxoSmithKline-CIHR Chair in Pharmacology. He is the founding co-director of the Sackler Institute for Epigenetics and Psychobiology at McGill and is a Fellow of the Canadian Institute for Advanced Research Experience-based Brain and Biological Development program. Szyf has been the founder of the first "Pharma" to develop epigenetic pharmacology "Methylgene Inc." and the first journal ...


Professor & Former Dean, Faculty of Pharmaceutical Sciences, University of British Columbia

Dr. Sindelar was appointed Dean of the Faculty of Pharmaceutical Sciences at UBC in 2002. This followed 19 years at the University of Mississippi where, for the last nine years of his tenure, he held the position of Professor and Chair of Medicinal Chemistry, School of Pharmacy. Dr. Sindelar is Dean of the Faculty of Pharmaceutical Sciences, UBC Dr. His expertise lies in medicinal chemistry, computer-aided drug discovery and design, and pharmaceutical biotechnology. He has published 45 refereed journal articles, 6 U.S. patents, several foreign patents. He serves as a member of the editorial ...


Professor and Dean Emeritus, University of British Columbia


Professor, University of Toronto

Dr. Anna Taddio, Professor, Leslie Dan Faculty of Pharmacy, and Senior Associate Scientist, The Hospital for Sick Children, is internationally recognized for her work related to pain management during medical procedures and the long-term harms of unmitigated pain. Dr. Taddio founded and currently leads a national inter-disciplinary, multi-sectoral team, Help Eliminate Pain in Kids and Adults (HELPinKids&Adults), investigating and promoting evidence-based pain management during vaccination. The World Health Organization adopted the recommendations from Dr. Taddio and her team in its first ...


Professor, Faculty of Medicine, Faculty of Pharmacy, University of Toronto

Jack Uetrecht is Professor in the Faculty of Pharmacy at the University of Toronto. His research has focused on the mechanism of idiosyncratic drug reactions with combined approaches involving organic chemistry, drug metabolism, reactive metabolites, immunology, molecular biology and clinical aspects. He holds a CRC chair in Adverse Drug Reactions and is internationally recognized as a leader in this field. He initiated the first Gordon Research Conference on Adverse Drug Reactions and was its first chair. He has chaired many committees including the Scientific Advisory Panel on ...


John Wallace has made important contributions to understanding the molecular mechanisms underlying the gastrointestinal ulcers and bleeding caused by aspirin and other nonsteroidal anti-inflammatory drugs. These are widely used drugs, particularly for treating arthritis, but their adverse effects are common and severe. Based on his mechanistic studies, he has designed and developed new hydrogen sulfide-releasing anti-inflammatory drugs that do not produce ulcers or bleeding, and is similarly working on novel drugs for the treatment of other inflammatory conditions, such as Crohn’s disease, ...


Professor, University of British Columbia